Great Valley Advisor Group, Inc.
- SEC CIK
- 0001769897
- Latest filing
- Aug 10, 2026
ELVN holding history
Enliven Therapeutics, Inc. in every 13F filed by Great Valley Advisor Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELVN overviewAll 13F holders of ELVNFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −13,660−100.0% | Sold out | Holders |
| Q4 2022 | 13,660 | $55.9K | <0.1% | −7,351−35.0% | Reduced | Holders |
| Q3 2022 | 21,011 | $48.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 21,011 | $26.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 21,011 | $40.0K | <0.1% | −1,600−7.1% | Reduced | Holders |
| Q4 2021 | 22,611 | $51.0K | <0.1% | −4,800−17.5% | Reduced | Holders |
| Q3 2021 | 27,411 | $112.0K | <0.1% | −4,800−14.9% | Reduced | Holders |
| Q2 2021 | 32,211 | $254.0K | <0.1% | +32,211 | New | Holders |